https://www.selleckchem.com/pr....oducts/Cryptotanshin
A total of 74 drug-indication pairs were found resulting in n = 296 observations; 8 percent (n = 23) were LWC and 55 percent (n = 163) were LWCMEA. A poor-to-moderate agreement existed between countries (-.29 κ .33) on LWCMEA decisions. Cross-country differences within the LWCMEA sample were partly driven by economic uncertainties and largely driven by SVJs considered across agencies. A set of HTA-related variables driving the uptake of MEAs across countries was identified. These findings can be useful in future resea
Like
Comment
Share
